New cancer drug shows early promise in Hard-to-Treat tumors
NCT ID NCT05774873
First seen Jan 09, 2026 · Last updated Apr 11, 2026 · Updated 17 times
Summary
This early-stage study tested a new drug called IBI334 in 28 adults with advanced solid tumors that could not be removed by surgery. The main goals were to check the drug's safety, determine the right dose, and see if it showed any signs of helping shrink tumors. Researchers measured side effects, how the drug moved through the body, and early signs of tumor response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Affiliated Cancer Hospital of Shandong First Medical university
Jinan, Shandong, 250117, China
Conditions
Explore the condition pages connected to this study.